Maxime Esvan
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
-
- Pharmaceutical industry and healthcare
Papers in
-
- Childhood Cancer Survivors' Quality of Life 3
-
- Acute Lymphoblastic Leukemia research 2
- Reproductive Health and Contraception 2
- Co-authors
- Valérie Vilgrain (4 shared papers)Christophe Aubé (4 shared papers)Maxime Ronot (4 shared papers)Gilles Châtellier (1 shared paper)Aurore Caumont‐Prim (1 shared paper)J. Lebigot (2 shared papers)Anthony Chapron (4 shared papers)Benjamin Bastian (2 shared papers)
- Journals
- Pediatric Blood & Cancer (2 papers)BMJ Open (1 paper)Blood (1 paper)BMC Infectious Diseases (1 paper)European Archives of Oto-Rhino-Laryngology (1 paper)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Maxime Esvan
34 papers receiving 619 citations
Peers
Comparison fields: 5 of 81
- Hepatology 218
- Pharmacology 36
- Radiology, Nuclear Medicine and Imaging 79
- Nephrology 24
- Epidemiology 98
Countries citing papers authored by Maxime Esvan
This map shows the geographic impact of Maxime Esvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Esvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Esvan more than expected).
Fields of papers citing papers by Maxime Esvan
This network shows the impact of papers produced by Maxime Esvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Esvan. The network helps show where Maxime Esvan may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxime Esvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 110 | |
| 2 | 2017 | 97 | |
| 3 | 2017 | 90 | |
| 4 | 2019 | 45 | |
| 5 | 2016 | 42 | |
| 6 | 2018 | 29 | |
| 7 | 2012 | 23 | |
| 8 | 2016 | 21 | |
| 9 | 2020 | 21 | |
| 10 | 2022 | 17 | |
| 11 | 2021 | 15 | |
| 12 | 2020 | 14 | |
| 13 | 2012 | 14 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2017 | 10 | |
| 17 | 2023 | 7 | |
| 18 | 2016 | 7 | |
| 19 | 2022 | 7 | |
| 20 | 2021 | 6 |
About Maxime Esvan
Maxime Esvan is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health, Physiology, Hepatology and Hematology, having authored 37 papers that have together received 631 indexed citations. Recurring topics across this work include Nutrition and Health in Aging (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Reproductive Health and Contraception (2 papers), Clinical Nutrition and Gastroenterology (2 papers) and Adolescent and Pediatric Healthcare (1 paper). The work is most often cited by research in Hepatology (218 citations), Pharmacology (36 citations), Radiology, Nuclear Medicine and Imaging (79 citations), Nephrology (24 citations) and Epidemiology (98 citations). Maxime Esvan has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Valérie Vilgrain, Christophe Aubé, Maxime Ronot, Gilles Châtellier, Aurore Caumont‐Prim, J. Lebigot, Anthony Chapron, Benjamin Bastian, Frédéric Balusson and Ronan Thibault. Their work appears in journals such as Pediatric Blood & Cancer, BMJ Open, Blood, BMC Infectious Diseases and European Archives of Oto-Rhino-Laryngology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.